These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23698064)

  • 21. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
    Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
    AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study.
    Palanee-Phillips T; Brown ER; Szydlo D; Matovu Kiweewa F; Pather A; Harkoo I; Nair G; Soto-Torres L; Hillier SL; Baeten JM;
    AIDS; 2019 Aug; 33(10):1619-1622. PubMed ID: 31306167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda.
    Kiddugavu M; Makumbi F; Wawer MJ; Serwadda D; Sewankambo NK; Wabwire-Mangen F; Lutalo T; Meehan M; Xianbin ; Gray RH;
    AIDS; 2003 Jan; 17(2):233-40. PubMed ID: 12545084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?
    Ssali A; Namukwaya S; Bufumbo L; Seeley J; G Lalloo D; Kamali A; Parkes-Ratanshi R
    PLoS One; 2013; 8(9):e73556. PubMed ID: 24039981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in contraceptive use among women with human immunodeficiency virus.
    Sun M; Peipert JF; Zhao Q; Wilson TE; Weber KM; Sanchez-Keeland L; DʼSouza G; Young M; Watts DH; Keller MJ; Cohan D; Massad LS
    Obstet Gynecol; 2012 Oct; 120(4):783-90. PubMed ID: 22996095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes.
    O'Brien SH; Koch T; Vesely SK; Schwarz EB
    Diabetes Care; 2017 Feb; 40(2):233-238. PubMed ID: 27899496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
    Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis.
    Rodriguez MI; Reeves MF; Caughey AB
    BJOG; 2012 Aug; 119(9):1067-73. PubMed ID: 22676150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers.
    Borgdorff H; Verwijs MC; Wit FW; Tsivtsivadze E; Ndayisaba GF; Verhelst R; Schuren FH; van de Wijgert JH
    Sex Transm Dis; 2015 Mar; 42(3):143-52. PubMed ID: 25668647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa.
    Ramjee G; Wand H
    Bull World Health Organ; 2012 Oct; 90(10):748-55. PubMed ID: 23109742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
    Morrison CS; Chen PL; Nankya I; Rinaldi A; Van Der Pol B; Ma YR; Chipato T; Mugerwa R; Dunbar M; Arts E; Salata RA
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):157-64. PubMed ID: 21358412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe.
    Morrison CS; Wang J; Van Der Pol B; Padian N; Salata RA; Richardson BA
    AIDS; 2007 May; 21(8):1027-34. PubMed ID: 17457097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal contraceptive use and risk of HIV-1 disease progression.
    Heffron R; Mugo N; Ngure K; Celum C; Donnell D; Were E; Rees H; Kiarie J; Baeten JM;
    AIDS; 2013 Jan; 27(2):261-7. PubMed ID: 23079806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of women who use hormonal contraceptives and their population-level impacts on HIV infection in a cohort of South African women (2002-2016).
    Wand H; Morris N; Reddy T
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):449-455. PubMed ID: 33140988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
    Pyra M; Heffron R; Mugo NR; Nanda K; Thomas KK; Celum C; Kourtis AP; Were E; Rees H; Bukusi E; Baeten JM;
    AIDS; 2015 Nov; 29(17):2353-9. PubMed ID: 26544706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing unintended pregnancy and HIV transmission: effects of the HIV treatment cascade on contraceptive use and choice in rural KwaZulu-Natal.
    Raifman J; Chetty T; Tanser F; Mutevedzi T; Matthews P; Herbst K; Pillay D; Bärnighausen T
    J Acquir Immune Defic Syndr; 2014 Dec; 67 Suppl 4(Suppl 4):S218-27. PubMed ID: 25436821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.